Variant report

Variant	nsv1045109
Chromosome Location	chr11:75869435-75904626
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:284)
CpG islands
(count:793)
Chromatin interactive
region (count:42)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:284 , 50 per page) page: 1 2 3 4 5 6

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr11:75877442-75877843	GM12878	blood:	n/a	n/a
2	ATF2	chr11:75877385-75877776	GM12878	blood:	n/a	n/a
3	BATF	chr11:75880537-75880793	GM12878	blood:	n/a	n/a
4	BATF	chr11:75877452-75877791	GM12878	blood:	n/a	n/a
5	BATF	chr11:75877503-75877745	GM12878	blood:	n/a	n/a
6	BATF	chr11:75880507-75880811	GM12878	blood:	n/a	n/a
7	BCL11A	chr11:75880481-75880847	GM12878	blood:	n/a	chr11:75880797-75880806
8	BCL11A	chr11:75877511-75877755	GM12878	blood:	n/a	chr11:75877743-75877752
9	BCL11A	chr11:75877450-75877789	GM12878	blood:	n/a	chr11:75877743-75877752
10	BHLHE40	chr11:75874344-75874627	K562	blood:	n/a	chr11:75874506-75874515 chr11:75874499-75874520 chr11:75874505-75874514 chr11:75874505-75874514 chr11:75874504-75874513
11	BHLHE40	chr11:75879567-75879848	K562	blood:	n/a	n/a
12	BHLHE40	chr11:75880588-75880997	GM12878	blood:	n/a	n/a
13	BHLHE40	chr11:75895960-75896047	K562	blood:	n/a	n/a
14	BHLHE40	chr11:75874450-75874566	GM12878	blood:	n/a	chr11:75874506-75874515 chr11:75874499-75874520 chr11:75874505-75874514 chr11:75874505-75874514 chr11:75874504-75874513
15	BHLHE40	chr11:75877454-75877762	GM12878	blood:	n/a	n/a
16	BHLHE40	chr11:75874343-75874668	HepG2	liver:	n/a	chr11:75874506-75874515 chr11:75874499-75874520 chr11:75874505-75874514 chr11:75874505-75874514 chr11:75874504-75874513
17	CBX3	chr11:75873978-75874336	K562	blood:	n/a	n/a
18	CCNT2	chr11:75872492-75872651	K562	blood:	n/a	n/a
19	CCNT2	chr11:75895841-75896045	K562	blood:	n/a	n/a
20	CEBPB	chr11:75901486-75901900	IMR90	lung:	n/a	n/a
21	CEBPB	chr11:75895861-75896066	K562	blood:	n/a	n/a
22	CEBPD	chr11:75895671-75896175	K562	blood:	n/a	n/a
23	CHD2	chr11:75880552-75880866	GM12878	blood:	n/a	n/a
24	CHD2	chr11:75877442-75877713	GM12878	blood:	n/a	n/a
25	CTCF	chr11:75893388-75893447	K562	blood:	n/a	n/a
26	CTCF	chr11:75886860-75887010	AG04449	skin:	n/a	chr11:75886958-75886971
27	CTCF	chr11:75893351-75893483	Hela-S3	cervix:	n/a	n/a
28	CTCF	chr11:75892580-75892730	WERI-Rb-1	eye:	n/a	chr11:75892629-75892637
29	CTCF	chr11:75875782-75875840	Spleen_OC	spleen:	n/a	n/a
30	CTCF	chr11:75892540-75892690	Caco-2	colon:	n/a	chr11:75892629-75892637
31	CTCF	chr11:75897220-75897370	BE2_C	brain:	n/a	n/a
32	CTCF	chr11:75873900-75874050	WERI-Rb-1	eye:	n/a	n/a
33	CTCF	chr11:75900080-75900230	WERI-Rb-1	eye:	n/a	n/a
34	CTCF	chr11:75893277-75893382	H1-hESC	embryonic stem cell:	n/a	n/a
35	CTCF	chr11:75892487-75892684	H1-hESC	embryonic stem cell:	n/a	chr11:75892629-75892637
36	CTCF	chr11:75886820-75886970	SK-N-SH_RA	brain:	n/a	n/a
37	CTCF	chr11:75892546-75892701	H1-hESC	embryonic stem cell:	n/a	chr11:75892629-75892637
38	CTCF	chr11:75886940-75887090	HepG2	liver:	n/a	chr11:75886958-75886971
39	CTCF	chr11:75897240-75897390	AG09319	gingival:	n/a	n/a
40	CTCF	chr11:75893220-75893370	Caco-2	colon:	n/a	n/a
41	CTCF	chr11:75900080-75900230	HUVEC	blood vessel:	n/a	n/a
42	E2F6	chr11:75904357-75904504	K562	blood:	n/a	n/a
43	E2F6	chr11:75872539-75872756	K562	blood:	n/a	n/a
44	EBF1	chr11:75877444-75877737	GM12878	blood:	n/a	n/a
45	EBF1	chr11:75880349-75881046	GM12878	blood:	n/a	n/a
46	EBF1	chr11:75880446-75880961	GM12878	blood:	n/a	n/a
47	EBF1	chr11:75880442-75880836	GM12878	blood:	n/a	n/a
48	EBF1	chr11:75875183-75875598	GM12878	blood:	n/a	chr11:75875387-75875396 chr11:75875360-75875371 chr11:75875421-75875432 chr11:75875423-75875432 chr11:75875385-75875396 chr11:75875423-75875433
49	EBF1	chr11:75877366-75877887	GM12878	blood:	n/a	n/a
50	EBF1	chr11:75875302-75875539	GM12878	blood:	n/a	chr11:75875387-75875396 chr11:75875360-75875371 chr11:75875421-75875432 chr11:75875423-75875432 chr11:75875385-75875396 chr11:75875423-75875433

(count:793 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr11:75897427-75897477	AG09309	skin:	n/a
2	chr11:75876135-75876185	LNCaP	prostate:	n/a
3	chr11:75898195-75898245	AG04450	lung:	fetal
4	chr11:75876419-75876469	BJ	skin:	n/a
5	chr11:75898132-75898182	HRPEpiC	eye:	n/a
6	chr11:75875926-75875976	HL-60	blood:	n/a
7	chr11:75898203-75898253	AG04450	lung:	fetal
8	chr11:75898203-75898253	SAEC	small airway:	n/a
9	chr11:75896332-75896382	AG04450	lung:	fetal
10	chr11:75898195-75898245	ovcar-3	ovarian:	n/a
11	chr11:75879348-75879398	PANC-1	pancreas:	n/a
12	chr11:75873027-75873077	AG10803	skin:	n/a
13	chr11:75875926-75875976	H1-hESC	embryonic stem cell:	embryo
14	chr11:75898132-75898182	MCF-7	breast:	n/a
15	chr11:75878127-75878177	NT2-D1	testis:	n/a
16	chr11:75876419-75876469	Caco-2	colon:	n/a
17	chr11:75896332-75896382	AG09309	skin:	n/a
18	chr11:75898195-75898245	HAEpiC	amniotic membrane:	n/a
19	chr11:75896332-75896382	SK-N-MC	brain:	n/a
20	chr11:75897427-75897477	AoSMC	blood vessel:	n/a
21	chr11:75898203-75898253	U87	brain:	n/a
22	chr11:75876135-75876185	NB4	blood:	n/a
23	chr11:75897427-75897477	NB4	blood:	n/a
24	chr11:75878127-75878177	SK-N-SH	brain:	n/a
25	chr11:75896332-75896382	NT2-D1	testis:	n/a
26	chr11:75897427-75897477	K562	blood:	n/a
27	chr11:75898203-75898253	GM12891	blood:	n/a
28	chr11:75896332-75896382	NH-A	brain:	n/a
29	chr11:75896332-75896382	RPTEC	kidney:	n/a
30	chr11:75904184-75904234	SK-N-MC	brain:	n/a
31	chr11:75902270-75902320	HUVEC	blood vessel:	n/a
32	chr11:75896332-75896382	SK-N-SH_RA	brain:	n/a
33	chr11:75897427-75897477	GM12878	blood:	n/a
34	chr11:75904184-75904234	MCF-7	breast:	n/a
35	chr11:75897427-75897477	IMR90	lung:	fetal
36	chr11:75879348-75879398	ProgFib	skin:	n/a
37	chr11:75902270-75902320	HIPEpiC	eye:	n/a
38	chr11:75897427-75897477	SK-N-SH_RA	brain:	n/a
39	chr11:75904184-75904234	K562	blood:	n/a
40	chr11:75878127-75878177	GM19239	blood:	n/a
41	chr11:75873027-75873077	HCF	heart:	n/a
42	chr11:75898132-75898182	HepG2	liver:	n/a
43	chr11:75898203-75898253	SK-N-SH	brain:	n/a
44	chr11:75898195-75898245	Hepatocyte	liver:	n/a
45	chr11:75898203-75898253	HL-60	blood:	n/a
46	chr11:75897427-75897477	HRPEpiC	eye:	n/a
47	chr11:75896332-75896382	PrEC	prostate:	n/a
48	chr11:75876135-75876185	MCF10A-Er-Src	breast:	n/a
49	chr11:75879348-75879398	AG04449	skin:	fetal
50	chr11:75898132-75898182	GM06990	blood:	n/a

(count:42 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr11:75902153..75903768-chr11:75945033..75947723,2	K562	blood:
2	chr11:75526830..75528448-chr11:75885826..75888721,2	K562	blood:
3	chr11:75865596..75868388-chr11:75876534..75879243,2	K562	blood:
4	chr11:75886596..75888940-chr11:75889618..75892110,2	MCF-7	breast:
5	chr11:75871119..75872885-chr11:75874380..75876840,2	MCF-7	breast:
6	chr11:75874099..75876373-chr11:75881253..75883763,2	MCF-7	breast:
7	chr11:75892849..75895480-chr11:75897932..75899434,2	K562	blood:
8	chr11:75886513..75888497-chr11:75907057..75909283,2	MCF-7	breast:
9	chr11:75886596..75888940-chr11:75889618..75892110,2	MCF-7	breast:
10	chr11:75887769..75890550-chr11:75903812..75906303,2	K562	blood:
11	chr11:75892849..75895759-chr11:75897789..75899434,2	K562	blood:
12	chr11:75879470..75881382-chr11:75903439..75906024,2	MCF-7	breast:
13	chr11:75887769..75890550-chr11:75903812..75906303,2	K562	blood:
14	chr11:75895372..75898295-chr11:75906346..75908229,2	K562	blood:
15	chr11:75891012..75893171-chr11:75895940..75897806,2	K562	blood:
16	chr11:75896186..75898075-chr11:75909574..75912491,2	K562	blood:
17	chr11:75679088..75681419-chr11:75870768..75873220,2	K562	blood:
18	chr11:75872410..75875308-chr11:75879381..75883436,3	K562	blood:
19	chr11:75891012..75893171-chr11:75895940..75897806,2	K562	blood:
20	chr11:75892849..75895759-chr11:75897789..75899434,2	K562	blood:
21	chr11:75898285..75900069-chr11:75902238..75904019,2	K562	blood:
22	chr11:75867883..75870652-chr11:75871506..75874252,2	MCF-7	breast:
23	chr11:75881616..75884148-chr11:75897760..75900480,2	MCF-7	breast:
24	chr11:75878808..75880535-chr11:75885544..75887523,2	K562	blood:
25	chr11:75888382..75891358-chr11:75893738..75896231,2	MCF-7	breast:
26	chr11:75888382..75891358-chr11:75893738..75896231,2	MCF-7	breast:
27	chr11:75898285..75900069-chr11:75902238..75904019,2	K562	blood:
28	chr11:75901884..75904848-chr11:76015737..76018383,2	MCF-7	breast:
29	chr11:75892849..75895480-chr11:75897932..75899434,2	K562	blood:
30	chr11:75864698..75867155-chr11:75871013..75872936,2	MCF-7	breast:
31	chr11:75877596..75879712-chr11:75888366..75889930,2	K562	blood:
32	chr11:75895025..75897686-chr11:75910991..75913944,2	K562	blood:
33	chr11:75864528..75867031-chr11:75871798..75873454,2	K562	blood:
34	chr11:75871119..75872885-chr11:75874380..75876840,2	MCF-7	breast:
35	chr11:75878808..75880535-chr11:75885544..75887523,2	K562	blood:
36	chr11:75901629..75903680-chr11:75921082..75923446,2	K562	blood:
37	chr11:75867883..75870652-chr11:75871506..75874252,2	MCF-7	breast:
38	chr11:75874099..75876373-chr11:75881253..75883763,2	MCF-7	breast:
39	chr11:75881616..75884148-chr11:75897760..75900480,2	MCF-7	breast:
40	chr11:75879470..75881382-chr11:75903439..75906024,2	MCF-7	breast:
41	chr11:75877596..75879712-chr11:75888366..75889930,2	K562	blood:
42	chr11:75872410..75875308-chr11:75879381..75883436,3	K562	blood:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-UVRAG-2	chr11:75901769-75901950	ENSG00000254933.1

No data

Variant related genes	Relation type
ENSG00000254933	TF binding region
ENSG00000254933	CpG island
ENSG00000085741	chromatin interactions

Extended variants
information (count: 1645 )
Associated
traits (count: 99 )

Variant overlapped rSNPs/rCNVs (count:1645 , 50 per page) page: 1 2 3 4 5 6 7 ... 33

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs367963690	chr11:75869480-75869481	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
2	rs577740908	chr11:75869518-75869519	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs368341568	chr11:75869529-75869530	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs375743548	chr11:75869531-75869532	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs4945033	chr11:75869535-75869536	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
6	rs188813604	chr11:75869543-75869544	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs137941759	chr11:75869610-75869611	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs4945034	chr11:75869615-75869616	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs76837399	chr11:75869633-75869634	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs564154356	chr11:75869634-75869635	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs533102106	chr11:75869656-75869657	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs115509345	chr11:75869661-75869662	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs569505378	chr11:75869680-75869681	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs528888757	chr11:75869690-75869691	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs142525370	chr11:75869710-75869711	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs150146477	chr11:75869720-75869721	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs4945035	chr11:75869737-75869738	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
18	rs538127780	chr11:75869763-75869764	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs376639915	chr11:75869770-75869771	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs367867103	chr11:75869797-75869798	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs112295497	chr11:75869913-75869914	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs117321605	chr11:75869939-75869940	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs537196559	chr11:75869940-75869941	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs557432099	chr11:75869963-75869964	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
25	rs138607030	chr11:75869988-75869989	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
26	rs573907079	chr11:75869991-75869992	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
27	rs543024281	chr11:75869997-75869998	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
28	rs149320671	chr11:75870023-75870024	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
29	rs376258359	chr11:75870127-75870128	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
30	rs541217073	chr11:75870142-75870143	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
31	rs564319183	chr11:75870149-75870150	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
32	rs538854574	chr11:75870155-75870156	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
33	rs12791559	chr11:75870158-75870159	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
34	rs4945036	chr11:75870179-75870180	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
35	rs563410614	chr11:75870197-75870198	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
36	rs544917122	chr11:75870217-75870218	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
37	rs144647864	chr11:75870228-75870229	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
38	rs77625437	chr11:75870237-75870238	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
39	rs559606593	chr11:75870247-75870248	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
40	rs572493944	chr11:75870255-75870256	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
41	rs191613291	chr11:75870264-75870265	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
42	rs116937409	chr11:75870288-75870289	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
43	rs140713110	chr11:75870306-75870307	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
44	rs537901776	chr11:75870321-75870322	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
45	rs75938555	chr11:75870345-75870346	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
46	rs550763160	chr11:75870372-75870373	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
47	rs567769177	chr11:75870381-75870382	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
48	rs143007112	chr11:75870395-75870396	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
49	rs553372175	chr11:75870398-75870399	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
50	rs74871671	chr11:75870403-75870404	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:99)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Gastric cancer	17908304	CNVD
Multiple myeloma	20724749	CNVD
Wilms tumour	21544195	CNVD
Autism	22495311	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Non-small cell lung cancer	21385341	CNVD
Intellectual disability	22102821	CNVD
Glioblastoma multiforme	21138945	CNVD
Acute myeloid leukemia	20729466	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	21637783	CNVD
Acute myeloid leukemia	16864856	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	21484798	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	21386901	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Cervical cancer	21063398	CNVD
Glioblastoma multiforme	19960244	CNVD
Liposarcoma	21253554	CNVD
Neuroblastoma	18923524	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Neuroblastoma	17533364	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Prostate cancer	18632612	CNVD
Smith-Lemli-Opitz syndrome	21572526	CNVD
Glioblastoma multiforme	21080181	CNVD
Multiple myeloma	16461302	CNVD
Cancer	16751803	CNVD
Seminomas	18059402	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Melanoma	18172304	CNVD
Breast cancer	22002566	CNVD
Ductal carcinoma	18381933	CNVD
Retinoblastoma	22278416	CNVD
Breast cancer	20953835	CNVD
oto-dental syndrome	17656375	CNVD
Asthma	21956041	CNVD
Breast cancer	17603634	CNVD
Ovarian neoplasms	16753589	CNVD
Non-small cell lung cancer	20864512	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	21509527	CNVD
Breast cancer	17001317	CNVD
Oral squamous cell carcinoma	16619035	CNVD
Intracranial aneurysm	16715129	CNVD
Colorectal cancer	16272173	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Colorectal cancer	16882699	CNVD
Berardinelli-seip congenital generalized lipodystrophy	17668395	CNVD
Spinal muscular atrophy	17668395	CNVD
Neonatal seizures	17668395	CNVD
Neonatal seizures	17668391	CNVD
Neuroticism	17667963	CNVD
Cancer	17916600	CNVD
Squamous cell cancer	19047905	CNVD
Multiple endocrine neoplasia type 1	19566914	CNVD
XY sex reversal	17503084	CNVD
Berardinelli-seip congenital generalized lipodystrophy	17668391	CNVD
Maculopathy	17646752	CNVD
Breast cancer	17899364	CNVD
Breast cancer	17157792	CNVD
Esophageal squamous carcinoma	18350619	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Cancer	20164919	CNVD
lymphocytic leukemia	21291569	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Cancer	22183965	CNVD
Melanoma	22183965	CNVD
Breast cancer	16620391	CNVD
Multiple myeloma	17550852	CNVD
Neuroblastoma	18923191	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Multiple myeloma	16616336	CNVD
Myelofibrosis	22110671	CNVD
Prostate cancer	17217626	CNVD
Cancer	22429812	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	21251322	CNVD
Lung cancer	18438408	CNVD
Breast cancer	21364760	CNVD
Breast cancer	21482786	CNVD
Ovarian cancer	20844748	CNVD
Breast cancer	16608533	CNVD
Usher syndrome	18421352	CNVD
Breast cancer	21858162	CNVD
Ovarian cancer	21240255	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:463 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:75833400-75872800	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
2	chr11:75864400-75871800	Weak transcription	Right Atrium	heart
3	chr11:75864600-75872600	Weak transcription	Fetal Intestine Large	intestine
4	chr11:75865000-75869600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
5	chr11:75865000-75876000	Weak transcription	Spleen	Spleen
6	chr11:75865800-75870400	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
7	chr11:75867800-75875200	Bivalent Enhancer	Fetal Muscle Trunk	muscle
8	chr11:75868000-75869800	Bivalent Enhancer	Fetal Stomach	stomach
9	chr11:75868200-75869600	Enhancers	Fetal Lung	lung
10	chr11:75868200-75870400	Bivalent Enhancer	Fetal Muscle Leg	muscle
11	chr11:75869200-75869600	Weak transcription	Pancreas	Pancrea
12	chr11:75869200-75871600	Weak transcription	Skeletal Muscle Female	skeletal muscle
13	chr11:75869200-75874400	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
14	chr11:75869400-75871600	Weak transcription	Fetal Heart	heart
15	chr11:75869400-75871600	Weak transcription	Skeletal Muscle Male	skeletal muscle
16	chr11:75869400-75872600	Weak transcription	Adipose Nuclei	Adipose
17	chr11:75869600-75870200	Weak transcription	Fetal Lung	lung
18	chr11:75869600-75872600	Enhancers	Pancreas	Pancrea
19	chr11:75869600-75873000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
20	chr11:75870000-75870200	Enhancers	Placenta	Placenta
21	chr11:75870000-75870400	Bivalent Enhancer	HepG2	liver
22	chr11:75870200-75870800	Enhancers	Fetal Lung	lung
23	chr11:75870200-75871800	Weak transcription	Placenta	Placenta
24	chr11:75870400-75870600	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
25	chr11:75870400-75874400	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
26	chr11:75870400-75874600	Enhancers	Fetal Muscle Leg	muscle
27	chr11:75870600-75873800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
28	chr11:75870800-75871400	Weak transcription	Fetal Lung	lung
29	chr11:75871000-75873600	Enhancers	Fetal Brain Male	brain
30	chr11:75871200-75871800	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
31	chr11:75871200-75872000	Enhancers	Cortex derived primary cultured neurospheres	brain
32	chr11:75871200-75872600	Enhancers	Brain Germinal Matrix	brain
33	chr11:75871200-75872600	Enhancers	Fetal Brain Female	brain
34	chr11:75871400-75871800	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
35	chr11:75871400-75873400	Enhancers	Fetal Lung	lung
36	chr11:75871600-75871800	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
37	chr11:75871600-75872000	Bivalent Enhancer	HepG2	liver
38	chr11:75871600-75872600	Enhancers	Skeletal Muscle Male	skeletal muscle
39	chr11:75871600-75872600	Enhancers	Skeletal Muscle Female	skeletal muscle
40	chr11:75871600-75873800	Enhancers	Fetal Heart	heart
41	chr11:75871800-75872000	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
42	chr11:75871800-75872400	Enhancers	Right Atrium	heart
43	chr11:75871800-75873000	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
44	chr11:75871800-75874400	Enhancers	Placenta	Placenta
45	chr11:75872000-75872200	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
46	chr11:75872000-75872400	Weak transcription	Cortex derived primary cultured neurospheres	brain
47	chr11:75872000-75872400	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
48	chr11:75872000-75872400	Bivalent Enhancer	Fetal Stomach	stomach
49	chr11:75872000-75872400	Enhancers	Right Ventricle	heart
50	chr11:75872000-75872400	Enhancers	K562	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links